SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-02
👔
Monopar Therapeutics
@MNPR_InsiderForm 4 Filing: Vu Quan Anh Surrenders for Taxes $46,943.13 of $MNPR
TAX WITHHOLDING
⚡ MATERIALITY: 4/10
corporate issuer
Monopar Therapeutics
Ticker: $MNPR
Transaction Value
$46,943.13
Price/Share: $27.06
transaction date
2026-06-30
Shares: 1,735
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Vu Quan Anh, holds the title of Chief Financial Officer at Monopar Therapeutics.
On 2026-06-30, the insider transacted 1,735 shares.The shares were transacted at a weighted average price of $27.06 per share, resulting in a total market-relevant value of $46,943.13.
Executive Summary Summary
Vu Quan Anh (Chief Financial Officer) had withheld for taxes $47K of $MNPR
Post-Transaction Position: 2,221 shares
SEC Accession No: 0001437749-26-022631 (CIK: 1892297)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.